首页 | 本学科首页   官方微博 | 高级检索  
     

NOK与FGFR2在非小细胞肺癌中的表达及临床意义
引用本文:刘海涛,张志培,葛忠虎,王雪娇,文苗苗,汪健,李小飞. NOK与FGFR2在非小细胞肺癌中的表达及临床意义[J]. 临床肿瘤学杂志, 2013, 18(12): 1071-1075
作者姓名:刘海涛  张志培  葛忠虎  王雪娇  文苗苗  汪健  李小飞
作者单位:第四军医大学唐都医院胸腔外科
摘    要:目的 检测含激酶结构域新原癌基因(NOK)与成纤维细胞生长因子受体2(FGFR2)在非小细胞肺癌(NSCLC)中的表达,分析其在不同病理类型、病理分级及临床TNM分期之间的表达差异及相关性。方法 应用免疫组化En Vision法检测NOK与FGFR2在163例NSCLC组织中的表达,分析其表达与病理类型、临床TNM分期、病理分级之间的关系,以及NOK与FGFR2表达的相关性。结果 NOK、FGFR2在163例NSCLC组织中的阳性表达率分别为66.7%和85.2%。NOK在肺鳞癌和肺腺癌中的阳性表达率分别为64.5%和72.6%,差异无统计学意义(P>0.05);NOK在不同TNM分期之间及在不同病理分级之间的表达差异均有统计学意义(P=0.000)。FGFR2在肺鳞癌和肺腺癌中的阳性表达率分别为88.6%和85.7%,差异无统计学意义(P>0.05);FGFR2在不同TNM分期之间及在不同病理分级之间的表达差异均有统计学意义(P<0.05)。NOK与FGFR2蛋白表达在NSCLC(r=0.640,P=0.000)、肺鳞癌(r=0.684,P=0.000)、肺腺癌(r=0.597,P=0.000)组织中均呈正相关。结论NOK与FGFR2在NSCLC中高表达,其表达与病理类型、病理分级及TNM分期有关,提示二者可能与NSCLC的发生和发展有关。

关 键 词:非小细胞肺癌  含激酶结构域新原癌基因(NOK)  成纤维细胞生长因子受体2(FGFR2)
收稿时间:2013-05-24
修稿时间:2013-10-11

Expressions of NOK and FGFR2 in non-small cell lung cancer and their clinical significance
LIU Haitao,ZHANG Zhipei,GE Zhonghu,WANG Xuejiao,WEN Miaomiao,WANG Jian,LI Xiaofei. Expressions of NOK and FGFR2 in non-small cell lung cancer and their clinical significance[J]. Chinese Clinical Oncology, 2013, 18(12): 1071-1075
Authors:LIU Haitao  ZHANG Zhipei  GE Zhonghu  WANG Xuejiao  WEN Miaomiao  WANG Jian  LI Xiaofei
Affiliation:Department of Thoracic Surgery, Tangdu Hospital, Fourth Military Medical University
Abstract:Objective To detect the expressions of novel oncogene with kinase-domain(NOK) and fibroblast growth factor receptor 2 (FGFR2) protein in non-small cell lung cancer(NSCLC),and analyze the expressions among different pathological types,pathological grades,TNM stages and their correlation.Methods The expressions of NOK and FGFR2 protein were detected with immunohistochemical En Vision method in 163 NSCLC samples,the expressions among different pathological types,pathological grades,TNM stages and the correlation between expressions of NOK and FGFR2 in tumor samples were analyzed.Results The positive rate of NOK and FGFR2 protein in 163 NSCLC tissues were 66.7% and 85.2%,respectively.The positive rate of NOK protein in lung squamous cell carcinoma and adenocarcinoma were 64.5% and 72.6% with no statistical difference (P 〉 0.05).NOK protein was expressed among different TNM stages with statistical difference(P =0.000),and the expressions also different in pathological grades(P=0.000).The positive rate of FGFR2 protein in lung squamous cell carcinoma and adenocarcinoma were 88.6% and 85.7% with no statistical difference(P 〉0.05).The expression of FGFR2 protein at different TNM stages and different pathological grades were also different statistically(P =0.000).The positive correlation between NOK and FGFR2 expression was found in NSCLC samples (r =0.640,P =0.000),squamous cell carcinoma(r =0.684,P =0.000) and adenocarcinoma(r =0.597,P =0.00).Conclusion NOK and FGFR2 protein are highly expressed in NSCLC,and their expressions correlates with pathological types,pathological grades and TNM stages,which may be related to the occurrence and development of NSCLC.
Keywords:Non-small cell lung cancer(NSCLC)  Novel oncogene with kinase-domain(NOK)  Fibroblast growth factor receptor 2 (FGFR2)
本文献已被 维普 等数据库收录!
点击此处可从《临床肿瘤学杂志》浏览原始摘要信息
点击此处可从《临床肿瘤学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号